We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Teva Ponies Up $2 Billion to Settle Protonix Patent Flap
Teva Ponies Up $2 Billion to Settle Protonix Patent Flap
June 14, 2013
Teva has reached a $2.15 billion settlement with Pfizer to resolve a long-running patent fight related to Pfizer’s acid reflux drug Protonix that had recently not been going in Teva’s favor.